- Home
- RHE vs PBM Comparison
RHE vs PBM Comparison
Compare RHE & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHE
- PBM
- Stock Information
- Founded
- RHE 1988
- PBM 1994
- Country
- RHE United States
- PBM Canada
- Employees
- RHE N/A
- PBM N/A
- Industry
- RHE Real Estate
- PBM
- Sector
- RHE Real Estate
- PBM
- Exchange
- RHE Nasdaq
- PBM NYSE
- Market Cap
- RHE 3.5M
- PBM 4.0M
- IPO Year
- RHE 2006
- PBM N/A
- Fundamental
- Price
- RHE $1.57
- PBM $0.05
- Analyst Decision
- RHE
- PBM
- Analyst Count
- RHE 0
- PBM 0
- Target Price
- RHE N/A
- PBM N/A
- AVG Volume (30 Days)
- RHE 27.3K
- PBM 8.8M
- Earning Date
- RHE 11-29-2024
- PBM 11-29-2024
- Dividend Yield
- RHE N/A
- PBM N/A
- EPS Growth
- RHE N/A
- PBM N/A
- EPS
- RHE N/A
- PBM N/A
- Revenue
- RHE $15,936,000.00
- PBM N/A
- Revenue This Year
- RHE N/A
- PBM N/A
- Revenue Next Year
- RHE N/A
- PBM N/A
- P/E Ratio
- RHE N/A
- PBM N/A
- Revenue Growth
- RHE N/A
- PBM N/A
- 52 Week Low
- RHE $1.13
- PBM $0.05
- 52 Week High
- RHE $3.08
- PBM $14.55
- Technical
- Relative Strength Index (RSI)
- RHE 43.01
- PBM 27.59
- Support Level
- RHE $1.13
- PBM $0.06
- Resistance Level
- RHE $2.11
- PBM $0.06
- Average True Range (ATR)
- RHE 0.15
- PBM 0.01
- MACD
- RHE -0.04
- PBM 0.00
- Stochastic Oscillator
- RHE 44.90
- PBM 1.07
About RHE Regional Health Properties Inc.
Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.